Cargando…

Deciphering the role of tau in neurodegeneration using Adeno-Associated Viral (AAV) vectors to express human tau in the mouse forebrain

Detalles Bibliográficos
Autores principales:	Lathuilière, Aurélien, Papin, Stéphanie, Cacquevel, Matthias, Paganetti, Paolo, Muhs, Andreas, Knott, Graham, Schneider, Bernard, Aebischer, Patrick
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2013
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3846748/ http://dx.doi.org/10.1186/1750-1326-8-S1-P27

Ejemplares similares

Motifs in the tau protein that control binding to microtubules and aggregation determine pathological effects
por: Lathuilière, Aurélien, et al.
Publicado: (2017)

Emerging Evidences for an Implication of the Neurodegeneration-Associated Protein TAU in Cancer
por: Papin, Stéphanie, et al.
Publicado: (2020)

Quantitative Methods for the Detection of Tau Seeding Activity in Human Biofluids
por: Lathuiliere, Aurelien, et al.
Publicado: (2021)

Perineuronal net digestion with chondroitinase restores memory in mice with tau pathology
por: Yang, Sujeong, et al.
Publicado: (2015)

The role of tau in neurodegeneration
por: Gendron, Tania F, et al.
Publicado: (2009)

Tau accumulation in degradative organelles is associated to lysosomal stress
por: Piovesana, Ester, et al.
Publicado: (2023)

Regulation of tau internalization, degradation, and seeding by LRP1 reveals multiple pathways for tau catabolism
por: Cooper, Joanna M., et al.
Publicado: (2021)

Adeno-Associated Virus (AAV) as a Vector for Gene Therapy
por: Naso, Michael F., et al.
Publicado: (2017)

Human Immune Responses to Adeno-Associated Virus (AAV) Vectors
por: Ronzitti, Giuseppe, et al.
Publicado: (2020)

Phosphorylation of nuclear Tau is modulated by distinct cellular pathways
por: Ulrich, Giorgio, et al.
Publicado: (2018)

A next-generation iPSC-derived forebrain organoid model of tauopathy with tau fibrils by AAV-mediated gene transfer
por: Shimada, Hiroko, et al.
Publicado: (2022)

Tau binding protein CAPON induces tau aggregation and neurodegeneration
por: Hashimoto, Shoko, et al.
Publicado: (2019)

Tau and DNA Damage in Neurodegeneration
por: Colnaghi, Luca, et al.
Publicado: (2020)

Sleep spindles, tau, and neurodegeneration
por: Neylan, Thomas C, et al.
Publicado: (2022)

Tau as a Biomarker of Neurodegeneration
por: Holper, Sarah, et al.
Publicado: (2022)

Tau affects P53 function and cell fate during the DNA damage response
por: Sola, Martina, et al.
Publicado: (2020)

Immunogenicity of Recombinant Adeno-Associated Virus (AAV) Vectors for Gene Transfer
por: Arjomandnejad, Motahareh, et al.
Publicado: (2023)

Untangling Tau and Iron: Exploring the Interaction Between Iron and Tau in Neurodegeneration
por: Rao, Shalini S., et al.
Publicado: (2018)

Human Tau Isoforms and Proteolysis for Production of Toxic Tau Fragments in Neurodegeneration
por: Boyarko, Ben, et al.
Publicado: (2021)

Parenchymal border macrophages regulate tau pathology and tau-mediated neurodegeneration
por: Drieu, Antoine, et al.
Publicado: (2023)

ARTAG in the basal forebrain: widening the constellation of astrocytic tau pathology
por: Liu, Alan King Lun, et al.
Publicado: (2016)

Alpha-synuclein and tau: teammates in neurodegeneration?
por: Moussaud, Simon, et al.
Publicado: (2014)

Author Correction: Tau binding protein CAPON induces tau aggregation and neurodegeneration
por: Hashimoto, Shoko, et al.
Publicado: (2019)

Glymphatic system clears extracellular tau and protects from tau aggregation and neurodegeneration
por: Ishida, Kazuhisa, et al.
Publicado: (2022)

Cancer-specific association between Tau (MAPT) and cellular pathways, clinical outcome, and drug response
por: Callari, Maurizio, et al.
Publicado: (2023)

Pre-Clinical Assessment of Immune Responses to Adeno-Associated Virus (AAV) Vectors
por: Basner-Tschakarjan, Etiena, et al.
Publicado: (2014)

Molecular design for recombinant adeno-associated virus (rAAV) vector production
por: Aponte-Ubillus, Juan Jose, et al.
Publicado: (2017)

Tau protein binds to the P53 E3 ubiquitin ligase MDM2
por: Sola, Martina, et al.
Publicado: (2023)

Tau, prions and Aβ: the triad of neurodegeneration
por: Reiniger, Lilla, et al.
Publicado: (2010)

Loss of tau rescues inflammation-mediated neurodegeneration
por: Maphis, Nicole, et al.
Publicado: (2015)

Nature of Tau-Associated Neurodegeneration and the Molecular Mechanisms
por: Yang, Ying, et al.
Publicado: (2018)

Contribution of Tau Pathology to Mitochondrial Impairment in Neurodegeneration
por: Pérez, María J., et al.
Publicado: (2018)

Aging-Related Tau Astrogliopathy in Aging and Neurodegeneration
por: McCann, Heather, et al.
Publicado: (2021)

Tau as a fluid biomarker of concussion and neurodegeneration
por: Hossain, Iftakher, et al.
Publicado: (2022)

Implication of tau propagation on neurodegeneration in Alzheimer’s disease
por: Lamontagne-Kam, Daniel, et al.
Publicado: (2023)

Brain aging, epigenetic changes, tau and neurodegeneration
por: Avila, Jesús
Publicado: (2021)

AAV-Tau Mediates Pyramidal Neurodegeneration by Cell-Cycle Re-Entry without Neurofibrillary Tangle Formation in Wild-Type Mice
por: Jaworski, Tomasz, et al.
Publicado: (2009)

Improved adeno-associated virus (AAV) serotype 1 and 5 vectors for gene therapy
por: Sen, Dwaipayan, et al.
Publicado: (2013)

Hepatocellular Carcinoma Is a Natural Target for Adeno-Associated Virus (AAV) 2 Vectors
por: Meumann, Nadja, et al.
Publicado: (2022)

Rapid characterization of adeno-associated virus (AAV) gene therapy vectors by mass photometry
por: Wu, Di, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_8lue36utkpmo9l7j441gklmmid